Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Patent
1995-05-18
2000-04-25
Brusca, John S.
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
435455, 514 44, 536 235, C12P 2106
Patent
active
060542888
ABSTRACT:
The present invention relates to transfected primary and secondary somatic cells of vertebrate origin, particularly mammalian origin, transfected with exogenous genetic material (DNA) which encodes a desired (e.g., a therapeutic) product or is itself a desired (e.g., therapeutic) product, methods by which primary and secondary cells are transfected to include exogenous genetic material, methods of producing clonal cell strains or heterogenous cell strains, methods of gene therapy in which the transfected primary or secondary cells are used, and methods of producing antibodies using the transfected primary or secondary cells.
The present invention includes primary and secondary somatic cells, such as fibroblasts, keratinocytes, epithelial cells, endothelial cells, glial cells, neural cells, formed elements of the blood, muscle cells, other somatic cells which can be cultured and somatic cell precursors, which have been transfected with exogenous DNA which is stably integrated into their genomes or is expressed in the cells episomally. The exogenous DNA either encodes a product, such as a translational product (e.g., a protein) or a transcriptional product (e.g., a ribozyme or an anti-sense nucleic acid sequence) which is a therapeutic product or is itself a therapeutic product (e.g., DNA which binds to a cellular regulatory protein or alters gene expression).
REFERENCES:
patent: 4396601 (1983-08-01), Salser et al.
patent: 4497796 (1985-02-01), Salser
patent: 4789550 (1988-12-01), Hommel et al.
patent: 4892538 (1990-01-01), Aebischer et al.
patent: 4980286 (1990-12-01), Morgan et al.
patent: 5082670 (1992-01-01), Gage et al.
patent: 5089397 (1992-02-01), Kushner et al.
patent: 5166059 (1992-11-01), Pastan et al.
patent: 5175255 (1992-12-01), Thomason et al.
patent: 5194596 (1993-03-01), Tischer et al.
patent: 5219740 (1993-06-01), Miller et al.
patent: 5272071 (1993-12-01), Chappel
patent: 5399346 (1995-03-01), Anderson et al.
patent: 5460959 (1995-10-01), Mulligan et al.
patent: 5789215 (1998-08-01), Berns et al.
Auchincloss et al. Xenogeneic Transplantation Annual Reviews in Immunology vol. 16 pp. 433-470, 1998.
Bennett et al. A role for cyclosporin A in gene replacerment therapy. Amer. J. Hum. Genet. vol. 45 p. A109, 1989.
Bennett et al. Suppression of Imminological response against a novel gene product delivered by implants of genetically modified fibroblasts. Mol. Biol. Med. vol. 7 pp. 471-477, 1990.
Chang et al. Autologous fibroblast implantation Feasibility and potential problems in Gene replacement therapy. Mol. Biol. Med. vol. 7 pp. 461-470, 1990.
Orkin et al. Report and Recommendations of the panel to assess the NIH investment in research on gene therapy, 1995.
Marshall Gene therapy's growing pains Science vol. 269 1050-1055, 1995.
Williams et al. Introduction of new genetic material into pluripotent haematopoietic stem cells of the mouse. Nature vol. 310 pp. 476-480, 1984.
Alberts et al. Molecular Biology of the Cell Garland Pub. Inc. New York pp. 160-165, 1983.
Shaham et al. Transfection of normal human and chinese hamster DNA corrrects diepoxybutane-induced chromosomal hypersensitivity of Fancomi anemia fibroblasts. Proc. Natl. Acad. Sci. USA vol. 84 pp. 5853-5857, 1987.
Selden et al. Implantation of geneticaly engineered fibroblasts into mice: Implications for gene therapy. Science vol. 236 pp. 714-718, 1987.
St. Louis et al. An alternative approach to somatic cell gene therapy. Proc. Natl. Acad. Sci. USA vol. 85 pp. 3150-3154, 1988.
Alberts, Molecular Biology of the Cell (Glossary), third edition, Garland Publishing, Inc., New York.
Brenner et al., Mol. Biol. Med. 7:105-15 (1990).
Chang et al., Biochem. Biophys. Act. 1092:153-160 (1991).
Duncan & Reddell, Biochemistry (Moscow), 621263-1274 (1997).
Keating et al., Prog. Clin. Biol. Res., 333:491-98 (1990).
Litwer et al., J. Biol. Chem., 264:14597-600 (1988).
Thompson et al., Cell., 56:313-21 (1989).
Camerini-Otero, "Right on Target," The New Biologist 2:337-341 (1990).
Capecchi, "High Efficiency Transformation by Direct Microinjection of DNA Into Cultured Mammalian Cells," Cell, 22:479-488 (1980).
Capecchi, "The New Mouse Genetics: Altering the Genome by Gene Targeting," TIG 5:70-76 (1989).
Crystal, "Transfer of Genes to Humans: Early Lessons and Obstacles to Success," Science 270:404-410 (1995).
Diatloff-Zito et al., "Abnormal Response to DNA Crosslinking Agents of Fanconi Anemia Fibroblasts can be Corrected by Transformation with Normal Human DNA," Proc. Natl. Acad. Sci. USA, 83:7034-7038 (1986).
Doetschman et al., "Targetted Correction of a Mutant HPRT Gene in Mouse Embryonic Stem Cells," Nature, 330:576-578 (1987).
Finn et al., "Homologous Plasmid Recombination Is Elevated in Immortally Transformed Cells," Mol. Cell. Biol., 9:4009-4017 (1989).
Frohman, "Cut, Paste, and Save: New Approaches to Altering Specific Genes in Mice," Cell, 56:145-147 (1989).
Heartlein et al., "Long-Term Production and Delivery of Human Growth Hormone," Proc. Natl. Acad. Sci. USA, 91:10967-10971 (1994).
Joyner et al., "Production of a Mutation in Mouse En-2 Gene by Homologous Recombination in Embryonic Stem Cells," Nature, 338:153-155 (1989).
Kaufman et al., "Strategies for Obtaining High Level Expression in Mammalian Cells," Technique 2:221-236, 1990.
Kriegler, "Gene Transfer and Expression: A Laboratory Manual", Stockton Press, New York (1990).
Kreymann et al., "Glucagon-Like Peptide-1 7-36: A Physiological Incretin In Man," The Lancet, 2:1300-1304 (1987).
Ledley, "Clinical Considerations in the Design of Protocols for Somatic Gene Therapy," Human Gene Therapy, 2:77-83 (1991).
Mansour, "Gene Targeting in Murine Embryonic Stem Cells: Introduction of Specific Alterations into the Mammalian Genome," Genet. Anal. Tech. Appl., 7:219-227 (1990).
Mes-Masson et al., "Expression of Oncomodulin Does Not Lead to the Transformation or Immortalization of Mammalian Cells In Vitro," J. Cell Science, 94:517-525 (1989).
Narayanan et al., "In Vivo Expression of a Nonselected Gene Transferred Into Murine Hematopoietic Stem Cells by Electroporation," Biochem. Biophys. Res. Commun. 141:1018-1024 (1986).
Ogura et al., "Implantation of Genetically Manipulated Fibroblasts into Mice as Antitumor .alpha.-Interferon Therapy," Cancer Research, 50:5102-5106 (1990).
Powell, "Human Erythropoietin Gene: High Level Expression In Stably Transfected Mammalian Cells and Chromosome Localization," Proc. Natl. Acad. Sci. USA, 83:6465-6469 (1986).
Sandhu et al., "Human Gene Therapy," Critical Reviews in Biotechnology, 17:307-326 (1997).
Selden et al., "Regulation of Insulin-Gene Expression," N. Eng. J. Med., 317:1067-1076 (1987).
Toneguzzo et al., "Stable Expression of Selectable Genes Introduced Into Human Hematopoietic Stem Cells by Electric Field-Mediated DNA Transfer," Proc. Natl. Acad. Sci. USA., 83:3496-3499 (1986).
Treco et al., "Non-Viral Gene Therapy," Molecular Medicine Today, 1:314-321 (1995).
Treco et al., "Fibroblast Cell Biology and Gene Therapy", Somatic Gene Therapy, ISBN 0-8493-2440-8:49-60 (1995).
Weatherall, "Scope and Limitations of Gene Therapy," British Medical Bulletin, 51:1-11 (1995).
Werner, "Expression of Transfected Genes by Differentiated, Postmitotic Neurons and Photoreceptors in Primary Cell Cultures," J. of Neuroscience Research 25:50-57 (1990).
Antin et al., "Single Cell Analysis of Transfected Gene Expression in Primary Heart Cultures Containing Multiple Cell Types," BioTechniques 6(7):640-648, 1988.
Behr et al., "Efficient Gene Transfer Into Mammalian Primary Endocrine Cells with Lipopolyamine-coated DNA," Proc. Natl. Acad. Sci. USA 86:6982-6986, 1989.
Brash et al., "Strontium Phosphate Transfection of Human Cells in Primary Culture: Stable Expression of the Simian Virus 409 Large-T-Antigen Gene in Primary Human Bronchial Epithelial Cells," Mol. Cell. Biol. 7(5):2031-2034, 1987.
Brigham et al., "Expression of a Prokaryotic Gene in Cultured Lung Endothelial Cells after Lipofection with a Plasmid Vector," Am. J. Respir. Cell Mol. Biol. 1:95-100, 1989.
Burrin et al., "Regulation of Transfected Glycoprotein Hormone .alpha.-Gene Expression in P
Heartlein Michael W.
Selden Richard F
Treco Douglas
Brusca John S.
Transkaryotic Therapies Inc.
LandOfFree
In vivo protein production and delivery system for gene therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with In vivo protein production and delivery system for gene therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and In vivo protein production and delivery system for gene therapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-992383